These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2219714)

  • 1. Reverse guanine phosphoribosyltransferase selection of recombinant vaccinia viruses.
    Isaacs SN; Kotwal GJ; Moss B
    Virology; 1990 Oct; 178(2):626-30. PubMed ID: 2219714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient marker stabilisation: a general procedure to construct marker-free recombinant vaccinia virus.
    Scheiflinger F; Dorner F; Falkner FG
    Arch Virol; 1998; 143(3):467-74. PubMed ID: 9572548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and isolation of recombinant vaccinia virus using genetic markers.
    Lorenzo MM; Galindo I; Blasco R
    Methods Mol Biol; 2004; 269():15-30. PubMed ID: 15114004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors.
    Falkner FG; Moss B
    J Virol; 1988 Jun; 62(6):1849-54. PubMed ID: 3130492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient selection during vaccinia virus recombination with insertion vectors without selectable markers.
    Kurilla MG
    Biotechniques; 1997 May; 22(5):906-10. PubMed ID: 9149873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An alternative genetic method to test essential vaccinia virus early genes.
    Kato SE; Greco FA; Damaso CR; Condit RC; Moussatché N
    J Virol Methods; 2004 Jan; 115(1):31-40. PubMed ID: 14656458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and characterization of a triple-recombinant vaccinia virus encoding B7-1, interleukin 12, and a model tumor antigen.
    Carroll MW; Overwijk WW; Surman DR; Tsung K; Moss B; Restifo NP
    J Natl Cancer Inst; 1998 Dec; 90(24):1881-7. PubMed ID: 9862625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insertional mutagenesis of the vaccinia virus gene encoding a type I DNA topoisomerase: evidence that the gene is essential for virus growth.
    Shuman S; Golder M; Moss B
    Virology; 1989 May; 170(1):302-6. PubMed ID: 2541548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein.
    Blasco R; Moss B
    J Virol; 1991 Nov; 65(11):5910-20. PubMed ID: 1920620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient expression system to measure the efficiency of vaccinia promoter regions.
    Shepard B; Panicali D; Huang C
    Plasmid; 1987 Jul; 18(1):16-23. PubMed ID: 3321110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. gpt-gus fusion gene for selection and marker in recombinant poxviruses.
    Cao JX; Upton C
    Biotechniques; 1997 Feb; 22(2):276-8. PubMed ID: 9043698
    [No Abstract]   [Full Text] [Related]  

  • 12. Vaccinia virus vectors utilizing the beta-galactosidase assay for rapid selection of recombinant viruses and measurement of gene expression.
    Panicali D; Grzelecki A; Huang C
    Gene; 1986; 47(2-3):193-9. PubMed ID: 3104141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dominant selectable marker for the construction of recombinant poxviruses.
    Boyle DB; Coupar BE
    Gene; 1988 May; 65(1):123-8. PubMed ID: 2840353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient dominant selection of recombinant vaccinia viruses.
    Falkner FG; Moss B
    J Virol; 1990 Jun; 64(6):3108-11. PubMed ID: 2159565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of recombinant vaccinia viruses.
    Earl PL; Moss B; Wyatt LS; Carroll MW
    Curr Protoc Protein Sci; 2001 May; Chapter 5():Unit5.13. PubMed ID: 18429179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of recombinant vaccinia virus LC16m0 or LC16m8: preserved laboratory attenuation markers and conserved expression of inserted HBsAg gene.
    Watanabe K; Morita M; Kojima A
    Vaccine; 1989 Dec; 7(6):499-502. PubMed ID: 2609725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of recombinant vaccinia viruses on the basis of plaque formation.
    Blasco R; Moss B
    Gene; 1995 Jun; 158(2):157-62. PubMed ID: 7607536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased antibody responses to human papillomavirus type 16 L1 protein expressed by recombinant vaccinia virus lacking serine protease inhibitor genes.
    Zhou J; Crawford L; McLean L; Sun XY; Stanley M; Almond N; Smith GL
    J Gen Virol; 1990 Sep; 71 ( Pt 9)():2185-90. PubMed ID: 2170578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An efficient method for generating poxvirus recombinants in the absence of selection.
    Rice AD; Gray SA; Li Y; Damon I; Moyer RW
    Viruses; 2011 Mar; 3(3):217-32. PubMed ID: 21494427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes.
    McCart JA; Ward JM; Lee J; Hu Y; Alexander HR; Libutti SK; Moss B; Bartlett DL
    Cancer Res; 2001 Dec; 61(24):8751-7. PubMed ID: 11751395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.